Primus In News
Shipping bottlenecks squeeze pharma flows as Hormuz crisis impact deepens
14-04-2026
Nilaya Varma, Co-founder and Chief Executive Officer, Primus Partners, shares his view on how geopolitical tensions are driving up input costs in India’s pharma sector due to heavy reliance on Chinese APIs and vaccine raw materials, delaying shipments and straining exports to Gulf and emerging markets
Explore Related Insights
- Beyond Adoption: AI-Driven Outcomes Become Internal Benchmark For Indian IT Giants
- Budget Reaction from Kanishk Maheshwari, Co-Founder & Managing Director, Primus Partners
- Budget expectations: Increased use of technology, export-promoting measures and reduced crop insurance premiums
- Empowering the Future: India Blockchain Forum Launches Web3.0 Ecosystem Directory
